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Abstract Human eukaryotic prohibitin (prohibitin-1 and
prohibitin-2) is a membrane protein with different cellular
localizations. It is involved in multiple cellular functions,
including energy metabolism, proliferation, apoptosis, and
senescence. The subcellular localization of prohibitin may
determine its functions. Membrane prohibitin regulate the
cellular signaling of membrane transport, nuclear pro-
hibitin control transcription activation and the cell cycle,
and mitochondrial prohibitin complex stabilize the mito-
chondrial genome and modulate mitochondrial dynamics,
mitochondrial morphology, mitochondrial biogenesis, and
the mitochondrial intrinsic apoptotic pathway. Moreover,
prohibitin can translocates into the nucleus or the mito-
chondria under apoptotic signals and the subcellular shut-
tling of prohibitin is necessary for apoptosis process.
Apoptosis is the process of programmed cell death that is
important for the maintenance of normal physiologi-
cal functions. Consequently, any alteration in the content,
post-transcriptional modification (i.e. phosphorylation) or
the nuclear or mitochondrial translocation of prohibitin
may influence cell fate. Understanding the mechanisms of
the expression and regulation of prohibitin may be useful
for future research. This review provides an overview of
the multifaceted and essential roles played by prohibitin in
the regulation of cell survival and apoptosis.
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Introduction
Prohibitin, a highly conserved group of proteins, are
ubiquitously expressed in many cell types and are
mainly located in the mitochondria, nucleus, and the
plasma membrane. Prohibitin-1 (PHB1) and prohibitin-2
(PHB2) are the two highly homologous subunits of the
eukaryotic mitochondrial PHB complex. PHB1 and
PHB2 are interdependent on the protein level, and loss
of one simultaneously leads to the loss of the other [1,
2]. Both PHB1 and PHB2 are composed of an N-ter-
minal transmembrane domain, an evolutionarily con-
served PHB domain that is similar to that of lipid raft-
associated proteins, and a C-terminal coiled-coil domain
that is involved in protein–protein interactions, including
the interaction between PHB1 and PHB2 as well as
transcriptional regulation. At the cell plasma membrane,
PHB is a transmembrane adaptor that activates down-
stream signal transduction [3]. In the nucleus, PHB
regulates transcriptional activation and the cell cycle. At
the mitochondrial inner membrane, 12–16 PHB1 and
PHB2 heterodimers associate to form a ring-like
macromolecular structure of approximately 1 MDa, with
no homodimers detected to date. This complex is
implicated in mitochondrial genome stabilization, mito-
chondrial morphology, oxidative stress, and apoptosis [3,
4]. Because PHB is closely associated with oxidative
stress and mitochondrial dysfunction, altering the sub-
cellular localization of PHB expression or targeting cell
surface PHB may provide promising strategies for the
treatment of inflammatory bowel disease, myocardium
injury, diabetes, cancer and obesity [3, 5].
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Apoptosis, a key regulator of tissue homeostasis, is
tightly regulated by the interactions of activating and
inhibitory pathways. Aberrant induction of cell apoptosis
may result in neurodegenerative diseases, chronic inflam-
matory diseases and autoimmune diseases among others.
Overexpression of PHB induces cellular resistance to var-
ious stimuli via the mitochondrial apoptotic pathway, while
knockdown of PHB increases susceptibility to apoptosis
stimuli. Stem cell studies also showed that ablation of
PHB2 caused massive apoptosis and early embryonic
lethality in mice [1, 6, 7]. However, the effect of PHB1 on
cell apoptosis and survival is complicated in cases of per-
sistent apoptosis resistance such as liver fibrosis and
tumorigenesis. Notably, PHB1 is required for gonado-
tropin-releasing hormone (GnRH)-induced cell apoptosis
of mature gonadotropins [8] and Tan IIA-induced apoptosis
of activated hepatic stellate cells (HSCs) [9]. In the field of
cancer, there are contradictory findings regarding the role
of PHB in cancer cell survival. Some studies showed that
knockdown of PHB increased cancer cell apoptosis [2, 10–
15]. However, other studies found that PHB1 deficiency
accelerated cancer cell growth and decreased cell apoptosis
[16–19]. Intriguingly, knockdown of PHB1 increased
cancer cell apoptosis in SGC7901 cells [13], but overex-
pression of PHB1 increased apoptosis in BGC823 cells
[18], and both lines are gastric carcinoma cells. The degree
of cancer cell differentiation may explain some of
these differences. Overall, it seems that the expression of
PHB, the stimuli and cell type may influence cell survival
and apoptosis.
A series of studies suggest that subcellular localization
may explain the paradoxical anti- and pro-apoptotic effect
of PHB on different cell types [20]. In mouse embryonic
fibroblasts (MEFs) and human cervical cancer HeLa cells,
PHB1 and PHB2 are mainly localized in the mitochondria,
and complete silencing of PHB1 or PHB2 causes mito-
chondrial network fragmentation followed by increased
mitochondria-mediated cell apoptosis under intrinsic and
extrinsic apoptotic stimuli [1, 2, 21]. In paclitaxel-resistant
lung cancer cells, PHB1 is mainly localized in the mito-
chondria and the plasma membrane, and knockdown of
PHB1 activates the intrinsic apoptotic pathway following
paclitaxel treatment both in vitro and in vivo [22]. Addi-
tionally, PHB2 is mainly localized in the mitochondria of
pluripotent mouse embryonic stem (ES) cells, and knock-
down of PHB2 causes induction of apoptosis in mouse ES
and human pluripotent stem (iPS) cells. Ectopic expression
of PHB2, but not a mitochondria-targeted signal-mutated
version of PHB2, effectively suppresses apoptosis, sug-
gesting that PHB2 localized in the mitochondria is crucial
to the survival of pluripotent ES cells [23]. However, in
invasive and noninvasive breast cancer cells, PHB1 is
mainly confined to the nucleus, in contrast to normal
epithelial breast cells in which PHB1 is located primarily in
the mitochondria [24]. In the MCF-7 and T47D breast
cancer cell lines, PHB1 is mainly located in the nucleus
[25, 26]; in the LNCaP prostate cancer cell line and the
MG-63 osteosarcoma cell line, the presence of PHB1
staining in the nucleus was also noted [27, 28]. Silencing
PHB1 enhanced the percentage of proliferating cells in the
population, as reflected by increased Brd/Urd incorpora-
tion, increased cell distribution in S phase and decreased
cell distribution in the G1–G0 phase of the cell cycle in
MCF-7 cells [26]. Consistently, in the HCT 116 human
colon carcinoma cell line, PHB1 was exclusively expressed
in the nucleus, while PHB2 appeared to be present in both
the cytoplasm and the nucleus, and knockdown of PHB1 or
PHB2 inhibited apoptosis induced by the topoisomerase I
inhibitor camptothecin in this cell type [29]. In a recent
study of human bladder cancer (BC), PHB1 was identified
as an important regulator during BC tumorigenesis in that it
is frequently overexpressed in BC tissues and significantly
correlated with poor prognosis in BC patients. Interest-
ingly, the overexpressed PHB1 was primarily found within
the mitochondria. It was also found that Akt phosphory-
lates PHB1 Thr258 in the cytoplasm without influencing the
total PHB 1protein level and promotes PHB1 mitochon-
drial translocation to induce BC proliferation [30]. All of
these observations suggest that in most cell types, mito-
chondrial and membrane-associated PHB is associated with
an anti-apoptosis function or tumorigenesis. Nevertheless,
nuclear PHB displays pro-apoptosis or anti-tumorigenic
properties. The subcellular localization and the regulation
of the transcription, translation, and posttranslational
modification of PHB may determine the final effect of
PHB on cell survival and apoptosis (Table 1).
PHB and control of apoptosis in the membrane
At the inner cell membrane, PHB1 can mediate the cellular
signaling of membrane transport. In cancer cells, PHB is
required for plasma membrane association of C-Raf and is
indispensable for the activation of the Ras-mediated Raf-
MEK-ERK signaling pathway, which may modulate cancer
cell survival and migration [31–33]. Rocaglamide (a fla-
vagline), a novel anticancer agent, can sensitize extrinsi-
cally induced apoptosis in resistant cancer cells [34].
Recently, rocaglamide was found to selectively bind to
PHB1 and PHB2 with nanomolar affinity and to influence
the membrane localization of PHB1 and PHB2 in the
human T cell leukemic cell line Jurkat, the human cervical
cancer cell line HeLa and the pancreatic cancer cell line
AsPC-1. This binding further disrupts the PHB/C-Raf
interaction at the inner cell membrane, arrests the cell cycle
at the G0/G1 phase and results in inactivation of the
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oncogenic Raf-MEK-ERK signaling pathway [32, 35, 36].
Although rocaglamide-induced loss of PHB1 and PHB2
membrane localization did not cause mitochondrial frag-
mentation in Jurkat or and HeLa cells and did not induce
distinct apoptosis in these cells, rocaglamide treatment
downregulated the G1/S regulatory proteins cyclin D3,
CDK4, CDK6, and cdc25A and inhibited cell cycle pro-
gression at the G1/S phase [35]. However, studies have
identified membrane-associated PHB1 as a pro-apoptosis
mediator in liver fibrosis. Appropriate removal of HSCs by
apoptosis is a potential strategy for the treatment of liver
fibrosis. In HSCs, upon Tan IIA stimulation, there is
increased translocation of C-Raf protein from the cyto-
plasm to the membrane as well as predominant PHB1
localization in the membrane. Knockdown of PHB1 causes
loss of PHB1 membrane localization and disruption of the
PHB1/C-Raf complex, which further attenuate Tan IIA-
induced apoptosis of activated HSCs [9].
On the cell surface, PHB1 also acts as specific receptor
in white fat vessels. PHB1 is abundant in the endothelial
cells of white adipose tissue in mice and humans, and the
membrane-associated PHB1 receptor is the target of an
adipose-specific peptide [37]. Thus, PHB1 can mediate the
internalization of the adipose-specific peptide [38]. A
subsequent study showed that cytochrome C-loaded
PHB1-targeted nanoparticles (PTNPs) induce apoptosis in
the endothelial cells of white fat vessels in vivo and prevent
diet-induced obesity (DIO) in a dose-dependent manner
in vitro. In addition, the delivery of a pro-apoptotic peptide
through PTNPs had no detectable liver toxicity and only
induced apoptosis in the adipose vasculature, not in
endothelial cells in other organs (such as heart, lung, liver,
spleen, and kidney), suggesting that a specific PHB1
receptor complex in the white adipose vasculature may
contribute to the induction of apoptosis as a mechanism of
treatment for obesity [38, 39]. The membrane localization
of PHB1 has an unusual ability to control apoptosis; it
clearly not only functions as a transmembrane signal re-
ceptor in the survival of cancer cells and the apoptosis of
HSCs but also mediates endocytosis in the induction of
apoptosis in the adipose vasculature (Fig. 1).
PHB and its transcriptional regulation
in the nucleus
Multiple lines of evidence indicate that nuclear-localized
PHB protein is a unique regulator of specific transcription
factors and cell cycle-associated proteins. This transcrip-
tional regulation function of PHB1 in the nucleus may
provide a link between the proliferative and apoptotic
pathways [25, 40, 41]. In general, PHB1 co-localized with
p53, Rb, E2F, AIF, c-myc, and c-fos in the nucleus [25, 27,
42–45]. These tumor-suppressor and oncogene proteins are
of great importance for mammalian cell apoptosis and
survival, and they usually function in a coordinated manner
[46]. In MCF7 cells, overexpression of PHB1 increased
p53-mediated and repressed E2F1-mediated transcriptional
activity [25]. In B cell lymphoma Ramos cells, overex-
pression of PHB1 upregulated p53-mediated transcription
and repressed E2F activity. It also protects cells from
camptothecin-induced apoptosis [47]. PHB1 does not
affect the receptor-mediated death of Ramos cells through
either the Fas or TNF pathways [47]. It is intriguing that
the PHB1 coiled–coil domain between amino acids 177
and 217 can mediate its homo-dimerization or its interac-
tion with heterologous proteins such as E2F1 and HDAC1,
and it can also repress E2F1-mediated transcription [48].
However, a putative PHB1 coiled-coil domain induced
caspase-dependent apoptosis of MCF7 and WI-38 cells,
although overexpression of full-length PHB1 protein
induced growth arrest, not apoptosis [48]. In addition, in
the human colon carcinoma cell line HCT 116, PHB1 and
PHB2 contribute to PIG3-mediated apoptosis by binding to
the P53 inducible gene 3 (PIG3) promoter (TGYCC)15
motif and initiating the transcription of PIG3 in the absence
of p53 [29]. Therefore, PHB is involved in both p53-de-
pendent and independent apoptotic processes (Fig. 1).
PHB and nuclear trafficking and apoptosis
PHB is a shuttle protein that shuttles between subcellular
compartments [43]. Newly synthesized PHB1 and PHB2 in
the cytoplasm or mitochondrially located PHB1 and PHB2
need to pass through the nuclear pore complex to translo-
cate into the nucleus, where they act as a transcriptional
modulator. It has been demonstrated that human PHB2
contains both an uncleavable mitochondrial targeting
sequence (MTS) at its N terminus and a nuclear localiza-
tion sequence at its C terminus [2]. Although human PHB1
does not possess the MTS, the N-terminal portion of PHB1
is also the sole determinant of mitochondrial targeting [2].
Moreover, the coiled-coil structure of the alpha helices in
the C terminus contains a leucine/isoleucine-rich nuclear
export sequence (NES) that facilitates the export of PHB to
the mitochondria or cytoplasm [5, 49]. This specific
structure of PHB proteins allows active shuttling between
the organelles.
The subcellular localization of PHB is affected by
apoptotic signals, and inhibition of this translocation
movement affects apoptosis. Proteomic analysis of apop-
tosis induced by the nuclear export inhibitor leptomycin
(LMB) of HeLa cells showed increased nuclear seques-
tration of PHB1 and Hsp27 and significant cytoplasmic
overexpression of PHB1 did not prevent LMB-induced
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apoptosis, but overexpression of Hsp27 partly inhibited
LMB-induced apoptosis [50]. The nuclear export of PHB1
is accompanied by many apoptotic events. In androgen-
sensitive and TGF-b-responsive human prostate cancer
cells, TGF-b treatment promoted PHB1 export from the
nucleus to the cytosol, which preceded apoptotic cell death
[51]. In camptothecin-induced apoptosis of the human
breast carcinoma cell line T47D, both PHB1 and p53
undergo export from the nucleus to the cytoplasm after
receiving apoptotic signals, and the nuclear exit of PHB1
and p53 correlate with the onset of apoptosis, as marked by
PARP cleavage [25]. A later study from the same group
showed that in the human osteosarcoma cell line Saos-2,
the breast cancer cell line MDA-MB231, and the non-small
cell lung carcinoma cell line H1299, camptothecin-induced
nuclear export of PHB1 does not require p53 [49]. How-
ever, the export of PHB1 from the nucleus under camp-
tothecin treatment in the breast cancer cell lines MCF-7
and T47D and the human fetal lung fibroblast cell line WI-
38 is dependent on the protein exportin 1 (CRM1) [49], a
member of the importin family. Furthermore, in MCF-7
cells, inhibition of the nuclear export of PHB1 by delivery
of a PHB-NES peptide without the NES prevents camp-
tothecin-mediated apoptosis [49]. In mature gonadotropes,
apoptosis of gonadotrope cells is crucial for the normal
development and function of the reproductive axis. GnRH
upregulates the expression of PHB1 mRNA via the JNK
pathway and induces PHB1 nuclear export through ERK
activation. The activation of the JNK pathway and the
subsequent activation of the pro-apoptotic factors BAX and
HRK, as well as the nuclear export of PHB1, is indis-
pensable for the GnRH-induced apoptosis of murine
gonadotrope-derived LbT2 cell lines; LMB or the ERK1/2
inhibitor U0126 inhibited the nuclear export of PHB1 and
reduced the levels of cleaved PARP under GnRH treatment
[8] (Fig. 2). In androgen-independent prostate cancer cells,
estrogen activates ERa and promotes mitochondrial-nu-
clear PHB1 translocation, leading to cancer cell resistance
Fig. 1 Schematic demonstration of PHB-mediated survival or apop-
tosis responses in multiple cellular compartments of different cell
types and molecular mechanism involved. At the outer plasma
membrane, PHB1 mediates the endocytosis of a pro-apoptotic peptide
in the induction of apoptosis in the adipose vasculature. At the inner
plasma membrane, membrane-localized PHB1 or PHB2 associate
with C-Raf and is involved in the activation of the Raf-mitogen-
associated protein kinase kinase (MEK)-extracellular signal-regulated
kinase (ERK) signaling pathway, which can promote cancer cell
survival. The serine/threonine-protein kinase (AKT) can phosphory-
late PHB1 in the cytoplasm and promotes PHB1 mitochondrial
translocation to induce bladder cancer proliferation. The anticancer
agent rocaglamides mediates the pro-apoptotic action by disrupting
the PHB1/C-Raf or PHB2/C-Raf interaction. However, increased
membrane localization of PHB1 and the PHB1/C-Raf complex in
activated hepatic stellate cells may promote Tan IIA-induced
apoptosis. The ring-shaped PHB complex in mitochondria may
regulate mitochondrial dynamics, mitochondrial morphology, mito-
chondrial genome, the electron transport chain (ETC), reactive
oxygen species (ROS) homeostasis, and anti-apoptotic proteins,
which further prevent mitochondria-mediated apoptosis. Nuclear
PHB1 co-localizes with many transcription factors, such as p53,
Rb, E2F, AIF, c-myc, and c-fos, which may influence the cell cycle
and tumor growth in a coordinated manner. PHB1 can upregulate
p53-mediated transcription but repress E2F activity in B cell
lymphoma cells, and overexpression of PHB1 protects cells from
camptothecin-induced apoptosis. In the absence of p53, both PHB1
and PHB2 can contribute to P53 inducible gene 3 (PIG3)-mediated
apoptosis by increasing the transcription of PIG3
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to paclitaxel [52]. However, the translocation of PHB1 from
the cytoplasm to the nucleus is also closely related to other
apoptotic events. In abrin (ABR)-induced apoptosis of
human Jurkat T leukemia cancer cells, downregulation of
PHB1 delays ABR-triggered cell apoptosis [16]. In the early
stages of apoptosis, PHB1 is upregulated by ABR through
the JNK/SAPK signaling pathway, which turns on the
expression of the pro-apoptotic gene Bax via the accumu-
lation and translocation of the PHB1-p53 complex to the
nucleus and the enhanced transcriptional activity of p53 on
Bax [16]. During apoptosis induced by ESC-3, an active
ingredient of crocodile bile, in human cholangiocarcinoma
Mz-ChA-1 cells, PHB1 is dramatically downregulated, and
the region of co-localization between PHB1 and AIF, p53,
Rb, and c-fos shifted from the cytoplasm to the nucleus. In
this case, PHB1 was expressed primarily in the cytoplasm
and only slightly in the nucleus of Mz-ChA-1 cells [45]. In
human breast cancer cells, the absence of brefeldin A-in-
hibited guanine nucleotide-exchange protein 3 (BIG3) pro-
moted the translocation of PHB2 to the nucleus after
estradiol stimulation and resulted in the suppression of
cancer cell growth. In contrast, PHB2 was trapped in the
cytoplasm in the presence of BIG3 with or without estradiol
stimulation, resulting in the constitutive activation of ER
signaling and tumorigenesis [53]. Capsaicin, a potential
anticancer agent, can directly bind to PHB2 and induced the
dissociation of PHB2 from adenine nucleotide translocator 2
(ANT2), thereby promoting the nuclear translocation of
PHB2 and cancer cell apoptosis [54] (Fig. 3). Moreover,
during the differentiation of human neuroblastoma SK-N-
SH cells, the region of colocalization of PHB1 with p53, Rb,
c-myc, and c-fos shifted from the nucleolus to the cytoplasm
[55]. In summary, the nuclear shuttling movement of PHB
correlates with signal transduction, cellular proliferation,
apoptosis, and differentiation.
PHB and its anti-apoptotic role in mitochondria
Mitochondria are essential organelles for all eukaryotic
cells. They execute the intrinsic apoptosis pathway in
response to various types of cell damage [56]. In multiple
studies, overexpression of PHB1 markedly prevented
mitochondria-mediated apoptosis triggered by apoptotic
stimuli. The main mechanism of this protective role is
PHB1-mediated inhibition of the intrinsic apoptotic path-
way by maintaining the mitochondrial transmembrane
potential, inhibiting cytochrome c release and caspase-3
activation, and enhancing the transcription and translation
of anti-apoptotic genes such as Bcl-2 and Bcl-xl [57–63].
Located in the mitochondrial inner membrane, the PHB
complex maintains mitochondrial dynamics and morphol-
ogy [64], which are essential for mitochondrial function
and cell survival [65]. In cardiomyocytes, forced expres-
sion of PHB1 attenuated mitochondrial fission and apop-
tosis induced by H2O2, and cardiac-specific PHB1
transgenic mice showed reduced mitochondrial fission and
myocardial infarction sizes after myocardial infarction
Fig. 2 The effect of inhibition of nuclear export of PHB1 on cell
apoptosis. In camptothecin-induced apoptosis of human breast carci-
noma cells, both PHB1 and p53 undergo export from the nucleus to the
cytoplasm upon receiving apoptotic signals. Nuclear export is depen-
dent on the exportin 1 (CRM1). Inhibition of the nuclear export of
PHB1 by delivery of a PHB1- nuclear export sequence (NES) peptide
lacking the NES prevents camptothecin-mediated apoptosis and it
didn’t affect the translocation of p53. In gonadotropin-releasing hor-
mone (GnRH)-induced apoptosis of mature gonadotrope cells, lepto-
mycin (LMB) or the extracellular signal–regulated kinase 1/2 (ERK1/
2) inhibitor U0126 inhibit the nuclear export of PHB1 and decrease
apoptosis
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injury [66]. Forced expression of PHB2 also attenuated
mitochondrial fission and apoptosis of cardiomyocytes
induced by anoxic conditions in vivo and vitro [67].
Ultrastructural studies have observed accumulated vesicu-
lar structures, striking absence of lamellar-shaped cristae,
impaired mitochondrial dynamics and augmented apoptosis
in PHB2-deficient cells [1, 23, 68, 69]. Knockdown of
PHB2 also induced loss of the longer Opa1 isoforms [1, 23,
69]. Anchored on the inner membrane of mitochondria,
Opa1 is required for the mitochondrial fusion and cristae
integrity, and loss of Opa1 commits cells to apoptosis
without any other stimuli [70, 71]. The cellular defects
observed in the PHB2-deficient cells are attributed to the
accelerated proteolytic cleavage of Opa1 L-isoforms to
S-isoforms (two long isoforms, L-Opa1; and three short
isoforms, S-Opa1) because ectopic expression of a prote-
olysis-resistant Opa1 mutant restored mitochondrial func-
tion and prevented apoptosis [1, 21]. It is clear that a pre-
existing mitochondrial morphology deficiency may render
cells more susceptible to apoptotic stimulation under PHB2
depletion [1].
In the early stages of apoptosis, mitochondrial cristae
are restructured, facilitating cytochrome c release from the
crystal lumen to the peripheral intermembrane space (IMS)
[72, 73]. Importantly, Opa1 self-assembly controls the
‘‘open’’ and ‘‘closed’’ states of the crista junction. The
oligomerization of L-Opa1 and S-Opa1 along with wider
crista junctions can block cytochrome c release and apop-
tosis [74, 75]. Another key step in initiating apoptosis is the
dissociation of the cytochrome c/cardiolipin complex and
the complete release of free cytochrome c into the cytosol
[76, 77], a process that can also be controlled by the lipid-
scaffold function of the PHB complex [4]. Indeed, as a
structuring scaffold, the PHB complex may govern spatial
membrane organization and regulate membrane protein
activities, both of which are required for optimal mito-
chondrial morphology and function [1, 4, 78]. Moreover,
the protection against apoptosis by Opa1 is independent of
mitochondrial fusion [74], and neither decreased mem-
brane potential nor respiratory activity was observed in the
absence of PHB2, suggesting that the Opa1-dependent
branch of apoptosis is involved in the activation of intrin-
sic apoptotic pathway [1].
An intriguing study in toxicology may provide further
information about the relationship between PHB complex
and Opa1 [21, 79]. Aurilide, a potent cytotoxic natural
marine product, inhibits the function of PHB complex and
accelerates the proteolytic processing of Opa1, results in
mitochondrial fragmentation and apoptotic cell death in
Hela cells [21]. However, aurilide selectively and directly
binds to PHB1 in the mitochondria and selectively disrupts
the PHB-m-AAA protease complex interaction rather than
the PHB1-PHB2 interaction [21]. It has been demonstrated
that the human m-AAA protease has limited effects on
Opa1 processing in human cells [21, 80–82], which is in
contrast to the effect in yeast [83]. The mitochondrial PHB
complex may indirectly regulate the proteolytic processing
or localization of Opa1 [21, 84].
The mitochondrial genome contains 37 genes encoding
22 mitochondrial tRNAs, 2 mitochondrial rRNAs and 13
proteins involved in the electron transport chain (ETC) that
are present in complexes I, III, IV and V (not II). The
mitochondrial genome is important for the synthesis of the
respiratory complex and maintenance of normal mito-
chondrial function [85]. A comprehensive DNA repair
system and sufficient mitochondrial biogenesis facilitate
Fig. 3 The subcellular shuttling
of PHB during cell apoptosis.
During the apoptosis of
gonadotrope cells induced by
GnRH and apoptosis of cancer
cells induced by camptothecin
or TGF-b, PHB1 is exported
from the nucleus to the
cytoplasm or mitochondria.
However, during the apoptosis
of cancer cells induced by abrin
or ESC-3, PHB1 translocates
from the cytoplasm or
mitochondria to the nucleus.
During the apoptosis of cancer
cells induced by estradiol or
capsaicin, PHB2 translocates
from the cytoplasm or
mitochondria to the nucleus
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cell survival in the presence of apoptotic stimuli [86, 87].
In contrast to nuclear DNA, mitochondrial DNA (mtDNA)
lacks introns and protective histones and is vulnerable to
oxidative damage due to its close proximity to the inner
membrane where reactive oxygen species (ROS) are con-
tinually produced. The major protein component of
mtDNA nucleoids, mitochondrial transcription factor A
(mtTFA), is involved in the repair and maintenance of
mtDNA and mitochondrial biogenesis [88–90]. MtTFA
knockout animals showed decreased mtDNA expression,
which leads to severe respiratory chain deficiency as well
as massive induction of apoptosis [91]. Importantly,
mitochondrial nucleoids are also located in the inner
mitochondrial membrane (IMM), and the PHB complex is
a peripheral component of mitochondrial nucleoids [92].
Therefore, the PHB complex may affect the attachment of
nucleoids to the IMM through functional partitioning.
Studies showed that depletion of PHB1 or PHB2 causes a
reduction in the mtDNA copy number and predisposes cells
to apoptosis [68, 69, 84]. Moreover, the PHB complex
maintains the copy number of mtDNA through mtTFA
regulation [84], but the PHB complex may affect the
organization of mitochondrial nucleoids neither by mtTFA-
dependent nor by Opa1-dependent pathway [84]. Interest-
ingly, PHB1 may preferentially maintain the nucleoid
organization compared with PHB2 [84]. Taken together,
these data show that the PHB complex maintains the
organization and stability of mitochondrial genome and
functions as essential survival factors.
As discussed above, the disorganization of mitochon-
drial nucleoids by PHB1 or PHB2 depletion leads to dis-
turbed mitochondrial biogenesis. When PHB1 expression
was decreased by siRNA transfection, the expression levels
of mtDNA-encoded subunits I and II (CoxI, CoxII) and
nDNA-encoded subunits IV and VIb (CoxIV, CoxVIb), as
well as Cox activity, all decreased [93]. Studies also con-
firmed that PHB1 or PHB2 silencing suppresses respiratory
chain complex activity [68, 69, 94] and partially blocks
mitochondrial electron transport [95], whereas overex-
pression of PHB1 increased complex I and complex IV
activity [96], improved respiration rates and restored ATP
formation [57, 63]. Interestingly, PHB1 is found to physi-
cally interact with respiratory chain complex I as well as
cytochrome c oxidase subunit II (CoxII) in the IMM [93,
97], which means that the PHB complex is required for the
detailed assembly and stability of respiratory chain com-
ponents [64, 98], either by affecting mitochondrial bio-
genesis or in a chaperon-like manner. Recent research
revealed that the respiratory chain can modulate apoptosis
in a context-dependent manner with no impact on ATP
production [99]. Respiratory chain dysfunction caused by
mtDNA mutations enhanced ROS production and changed
the complement of anti-apoptotic proteins in the
mitochondria [99]. Therefore, in PHB-deficient cells,
blockage of the ETC caused by partial damage to respira-
tory chain complexes strongly enhanced the sensitization
of these cells to the induction of apoptosis.
Mitochondria are a major source of ROS, and the PHB
complex is involved in the regulation of ROS. ROS are a
byproduct of mitochondrial respiration, and their formation
is mainly due to natural electron leakage occurring at res-
piratory chain complexes I, II and III. Continued oxidative
stress can lead to mtDNA, lipid and protein damage and
defects in signaling transduction pathways, affecting the
onset of apoptotic cell death [100]. Multiple studies have
documented that PHB1 expression is enhanced in various
stress conditions [62, 93, 96, 101, 102] and is decreased in
intestinal epithelial cells during oxidative stress [103].
During oxidative stress, PHB1 can be exported from the
nucleus to the mitochondria [43, 49, 104]. Moreover,
knockdown of PHB1 enhanced ROS production [14, 94–96],
whereas exogenous PHB1 not only decreased basal intra-
cellular ROS levels [105] but also decreasedROSproduction
and prevented apoptosis in stress conditions [57, 96, 105–
108], suggesting that PHB1 is an endogenous protective
protein that can alleviate damage due to oxidative stress.
Because ETC is the major source of ROS generation and
PHB1 directly regulates its activity [93, 97], it is not sur-
prising that PHB1 is in control of ROS production. It seems
that PHB1 dampens complex I-generated ROS, but not
complex-III [96], which is also the site of superoxide pro-
duction. In addition to suppressing ROS production, PHB1
also upregulates antioxidant enzymes to combat excess
ROS. A handful of experimental observations depict how
PHB1 is involved in the maintenance of ROS homeostasis.
PHB1 overexpression restores the GSH/glutathione
S-transferase antioxidant system [109] and activates
antioxidant response element (ARE) 4 as well as the tran-
scription of the antioxidant enzymes NAD(P)H quinone
oxidoreductase-1 (NQO-1) and heme oxygenase-1 (HO-1),
ultimately reducing the incidence of apoptosis [105]. Further
investigation suggests that the activation ofARE is due to the
activation of ERK, which has been shown to contribute to
ARE activation through activation of the transcription factor
AP-1 [105]. In PHB1-overexpression colitis mice models,
ERK1/2, c-Fos, c-Jun, HO-1, andNQO-1 levels all increased
[105]. Although nuclear factor erythroid 2-related factor 2
(Nrf2) is also the principal transcription factor that binds to
ARE [110] and Nrf2 mRNA, and Nrf2 protein expression as
well as Nrf2/DNA binding is sustained in PHB1 overex-
pression under oxidative stress [106], the upregulation of
antioxidants HO-1 and NQO-1 occurs via a mechanism
independent of Nrf2 in this condition [105].
In addition to the influence on mitochondrial dynamics,
mitochondrial morphology, mitochondrial genome, ETC,
and ROS, mitochondrial PHB complex also interacts with
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the anti-apoptotic Hax-1 protein. Hax-1, the hematopoietic
cell-specific protein-associated protein X-1, is a nucleo-
cytoplasmic shuttling protein and functions in the apoptotic
cascade upstream from caspase activation [2]. In Hela
cells, PHB2 directly bound to Hax-1 in the mitochondria
[2]. And knockdown of PHB2 reduced Hax-1 expression
and induced caspase-dependent apoptosis [2]. In the
mitochondria, Hax-1 is integrated in the outer mitochon-
drial membrane and localized in the intermembrane space.
Because Hax-1 can be proteolytically degraded by the
Omi/HtrA2 protease [111], it is suspected to be protected
by the PHB complex. It is worth noting that knockdown of
Hax-1 induces apoptotic cell death without damaging
normal mitochondrial morphology [2].
Overall, deficiency in the PHB complex in the mito-
chondria may lead to programmed cell death due to its
adverse impact on mitochondrial dynamics, mitochondrial
morphology, mitochondrial genome, ETC, ROS home-
ostasis, as well as other anti-apoptotic proteins. Conse-
quently, these events sustain and interact with each other,
giving rise to a vicious cycle of mitochondrial dysfunction,
furthering mitochondria-mediated apoptosis (Fig. 1).
PHB post-transcriptional modification
and the implication in apoptosis
Many mitochondrially localized proteins involved in the
apoptotic process are functionally affected by phosphoryla-
tion, which can ultimately dictate whether a cell lives or dies
[112]. PHB is one example. Studies have found that the
phosphorylation sites of PHB1 include Ser252, Ser254, Sr265,
and Thr258 as well as four tyrosine residues (Tyr28, Tyr114,
Tyr249, and Tyr259) [113, 114]. The posttranslational modifi-
cation of PHB potentiates the signal pathways involved in cell
apoptosis, survival, and differentiation [113, 115–117]. Upon
activation of primary human T cells, PHB1 was phosphory-
lated on serine residue(s), and PHB2 was phosphorylated on
serine and tyrosine residues. These up-regulated proteins
function to regulate mitochondrial homeostasis and T cell
viability and differentiation [115]. In staurosporine-treated
undifferentiated granulosa cells (GCs), increased mitochon-
drial PHB1 levels suppress the expression of the major pro-
apoptotic factors Bax and Bak. MEK inhibitors abate the
phosphorylation of PHB1 and enhance the release of cyto-
chrome C and apoptosis [59]. Studies have also found that
PHB is a substrate for Akt both in vitro and in vivo [30, 40,
117, 118]. In prostate cancer cells, TGF-b activation of the
Raf-MEK-ERK-PKC-d intracellular signal pathway leads to
PHB1 phosphorylation and decreases inner mitochondrial
permeability, cell survival, and cell invasion. In contrast,
upregulating the 14-3-3 protein results in PKC-d inhibition,
PHB1 dephosphorylation, and increased cell apoptosis [40].
The phosphorylation status of PHB1 may act as a ‘‘molecular
switch’’ for cell apoptosis during TGF-b stimulation. In
MiaPaCa-2 pancreatic cancer cells,Akt phosphorylatesPHB1
at Thr258 but does not phosphorylate PHB2 [117]. In NB4
human leukemia cells, PHB2 is phosphorylated by Akt on
Ser91 andSer176, and dephosphorylation ofPHB2Ser91 results
in rapid cellular apoptosis [118]. The phosphorylation status
of PHB1 can also affects the phosphorylation or activation of
Akt [33, 57, 58, 68, 95, 119]. For example, phosphorylation of
PHB1 onThr258 in the raft domain of the plasmamembrane is
required for the activation of Ras-induced Raf-MEK-ERK
and the PI3 K/Akt pathways, which promote tumor cell pro-
liferation and metastasis [33, 119]. This indicate a compli-
cated regulation network between the prosurvival kinase Akt
and its substrate PHB. Apart from phosphorylation, PHB is
also regulated by several other post-transcriptional modifi-
cations, such as O-GlcNAc modifications, palmitoylation,
transamidation, and tyrosine nitrosylation [114]. Because
O-GlcNAcmodification and tyrosinephosphorylation ofPHB
can affect each other [116], whether there is any association
between apoptosis regulation and other post-transcriptional
modifications warrants further investigation. The delineation
of the regulation and functional consequences of these post-
transcriptional events will be important to understanding the
regulatory complexity of apoptosis.
Another potential mechanism of post-transcriptional reg-
ulation of PHB is mediated by microRNA. MicroRNA can
directly bind to the PHB 30-UTR and induce cleavage of PHB
mRNA, resulting in loss of function. In glioma cells, the
oncomiR microRNA-26a promotes tumor growth and
angiogenesis by targeting PHB1 [120]. Similarly, in prostate
cancer and gastric cancer cells, microRNA-27a promotes
tumor growth by directly targeting PHB1 [121]. However, in
glioma cells, microRNA-27a promotes apoptosis by
decreasing PHB1 protein expression [122]. Likewise, in
mature gonadotropes, microRNA-27 downregulates PHB1
protein levels, and this is associated with an apoptotic
response in the normal development and function of the
reproductive axis [8]. In cardiomyocytes, miR-539 targets
PHB2 and induces mitochondrial fission and apoptosis under
anoxia injury. Cardiac apoptosis-related lncRNA (CARL)
inhibits cell apoptosis by impairing miR-539-dependent
PHB2 downregulation [67]. Therefore, not only PHBproteins
levels but also its activity may ultimately determine cell fate.
Conclusions
Taken together, the data presented here point to a critical
role of PHB in cell survival and apoptosis. Importantly, the
contribution of PHB to apoptosis is dependent on their
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cellular localization, the cell type, and post-transcriptional
modifications. Because altered PHB signaling is implicated
in a range of apoptosis-associated events, intense efforts
should be directed at improving the understanding of the
nuclear trafficking and transcriptional regulation of PHB
and its target genes. Targeting PHB may have inspiring
prospects in the future therapy of apoptosis-associated
diseases.
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